EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
University of Tübingen · Hospital Universitario del Sureste · +32 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
636
total citations
- FWCI
- 153.65
- Percentile
- 100%
- References
- 242
Citations per year
Authors
27Topics & keywords
Topics
Keywords
- Medicine
- Rituximab
- Microscopic polyangiitis
- Azathioprine
- Granulomatosis with polyangiitis
- Vasculitis
- Anti-neutrophil cytoplasmic antibody
- Prednisolone
No related works found for this paper.
Funding
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- SSanofi
- CCelgene
- CBCSL Behring
- KPKiniksa Pharmaceuticals
- CCelltrion
- NINational Institute for Health and Care Research
- NNierstichtingAward: 17OKG04
- HRHellenic Rheumatology Society
- LULeids Universitair Medisch Centrum
- NANational and Kapodistrian University of Athens
- VPVifor Pharma
- DADutch Arthritis Association
- IInflaRx
- GGenentech
- ESEMD Serono
- CPChugai Pharmaceutical
- EAEngineering and Physical Sciences Research CouncilAward: EP/Y019393/1
- NCNIHR Cambridge Biomedical Research Centre